GoodRx Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GOODRX HOLDINGS, INC. | ||
| Date: February 27, 2025 | By: | /s/ Christopher McGinnis |
|---|---|---|
| Christopher McGinnis | ||
| Chief Financial Officer & Treasurer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Wendy Barnes | Chief Executive Officer, President & Director | February 27, 2025 |
| Wendy Barnes | (Principal Executive Officer) | |
| /s/ Christopher McGinnis | Chief Financial Officer & Treasurer | February 27, 2025 |
| Christopher McGinnis | (Principal Financial Officer) | |
| /s/ Romin Nabiey | Chief Accounting Officer | February 27, 2025 |
| Romin Nabiey | (Principal Accounting Officer) | |
| /s/ Trevor Bezdek | Co-Chairman & Director | February 27, 2025 |
| Trevor Bezdek | ||
| /s/ Scott Wagner | Co-Chairman & Director | February 27, 2025 |
| Scott Wagner | ||
| /s/ Christopher Adams | Director | February 27, 2025 |
| Christopher Adams | ||
| /s/ Ronald E. Bruehlman | Director | February 27, 2025 |
| Ronald E. Bruehlman | ||
| /s/ Ian T. Clark | Director | February 27, 2025 |
| Ian T. Clark | ||
| /s/ Dipanjan Deb | Director | February 27, 2025 |
| Dipanjan Deb | ||
| /s/ Douglas Hirsch | Director | February 27, 2025 |
| Douglas Hirsch | ||
| /s/ Kelly J. Kennedy | Director | February 27, 2025 |
| Kelly J. Kennedy | ||
| /s/ Gregory Mondre | Director | February 27, 2025 |
| Gregory Mondre | ||
| /s/ Agnes Rey-Giraud | Director | February 27, 2025 |
| Agnes Rey-Giraud | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-1 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Stockholders’ Equity | F-5 |
| Consolidated Statements of Cash Flows | F-6 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.